Relief Cardiovascular is a company focused on pioneering innovative solutions for the management of heart failure. As part of the inQB8 Medical Technologies portfolio, the company is developing the Relief System, a transcatheter smart implant designed to monitor and modulate renal vein pressures. This novel approach aims to improve fluid management in heart failure patients, enhancing both safety and efficacy.
Leadership & Board
Current Number of Employees18
Current LinkedIn Followers2,988
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Relief Cardiovascular had 18 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Relief Cardiovascular had 2,988 followers as of September 28, 2026. The number of followers increased by 26 (0.88%) week-over-week.
2,988Latest Followers Count
26(0.88%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.